A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma (Q34617756)
scientific article
Language:
(P31) (Q13442814)
(P304) 320-324
(P433) 5
(P478) 85
(P577) Saturday, May 1, 2010
(P921) (Q42824440)
(Q209369)
(P1433) (Q4744246)
(P1476) "A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma" (language: en)
(P2093) Patrick B Johnston
David J Inwards
Joseph P Colgan
Betsy R Laplant
Brian F Kabat
Thomas M Habermann
Ivana N Micallef
Luis F Porrata
Stephen M Ansell
Craig B Reeder
Vivek Roy
Thomas E Witzig
(P2860) (Q33816583)
(Q42152675)
(Q33385283)
(Q29547625)
(Q39861488)
(Q24655791)
(Q41876102)
(Q29618031)
(Q33379949)
(Q37326210)
(Q36742629)
(Q33377828)
(Q33375800)
(Q29618608)
(Q40234467)
(Q36568861)
(Q36384467)
(Q40377835)
(Q33366976)
(Q40424155)
(Q34397003)
(Q40457592)
(Q29614242)
(Q34524632)
(Q33773306)
(Q39795545)
(Q34726922)
(Q46412217)
(Q33920766)
(Q43290574)
(Q46074748)
(Q46942053)
(Q53551590)
(Q44551425)
(Q47748021)
(Q74409841)
(Q80209074)
(Q56943090)
(Q33414529)
(Q105219584)
other details
description scientific article

External Links